Chapman Gina

Chapman Gina is listed in filings as Director at Entrada Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 12, 2025, including sale activity. Recent filings connect the profile to Entrada Therapeutics, Inc. (TRDA) and CARGO Therapeutics, Inc. Common Stock (CRGX). The current snapshot covers public activity from Jun 14, 2024 to Jun 12, 2025. Reported amounts are shown as $150.1K to $15.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.